I Ask This Of You!

I have Parkinson's diseases and thought it would be nice to have a place where the contents of updated news is found in one place. That is why I began this blog.

I copy news articles pertaining to research, news and information for Parkinson's disease, Dementia, the Brain, Depression and Parkinson's with Dystonia. I also post about Fundraising for Parkinson's disease and events. I try to be up-to-date as possible.

I am not responsible for it's contents. I am just a copier of information searched on the computer. Please understand the copies are just that, copies and at times, I am unable to enlarge the wording or keep it uniformed as I wish.

This is for you to read and to always keep an open mind.

Please discuss this with your doctor, should you have any questions, or concerns.

Never do anything without talking to your doctor. I do not make any money from this website. I volunteer my time to help all of us to be informed. I will not accept any information about Herbal treatments curing Parkinson's, dementia and etc. It will go into Spam.

This is a free site for all with no advertisements.

Thank you for visiting!

Thursday, June 29, 2017

FoxFeed Blog :Ask the MD: New Video and Guide on Repurposed Therapies in Parkinson's Disease

Rachel Dolhun, MD    
June 27, 2017

Many people with Parkinson's are anxiously awaiting better treatments for their symptoms, and everyone with the disease is hoping for a therapy to slow or stop its progression. So the decade or more it takes to move a drug from discovery of a new compound to patients' hands is frustratingly long.
Enter repurposing -- a strategy that could potentially reduce time and costs associated with drug development. Repurposing, sometimes referred to as repositioning, is taking drugs that often are already approved by the U.S. Food and Drug Administration (FDA) to treat one condition and using them to treat another. (Repurposing also can apply to drugs still under investigation for other conditions and to over-the-counter supplements.) Several repurposed therapies are currently in varied phases of clinical testing to evaluate safety or potential benefit in Parkinson's.
The bottom line? Repurposing is an attractive strategy to potentially decrease time and costs of Parkinson's drug development. But it doesn't eliminate the need for clinical trials. Proceed with caution if you're contemplating adding a repurposed therapy to your Parkinson's regimen before testing is complete.
Watch the video for more on how researchers decide which drugs to repurpose, why additional clinical trials are necessary, and what patients and providers can consider if thinking about pursuing repurposed therapies before trials are complete.
For a deeper dive on this topic, download our new guide, "Repurposed Therapies in Parkinson's Disease: What Patients and Families Need to Know." This free resource provides an overview of repurposing, a discussion of what to consider with your provider if you're thinking about taking a repurposed therapy while it's still in testing (i.e., "off label"), and examples of therapies in clinical trials for repurposing in Parkinson's.

No comments:

Post a Comment